Display options
Cite
Du X, Shao Y, Gao H, et al. . Cancer Biol Ther. 2018;19(11):962-966doi: 10.1080/15384047.2018.1480282.
Du, X., Shao, Y., Gao, H., Zhang, X., Zhang, H., Ban, Y., Qin, H., & Tai, Y. (2018). . Cancer biology & therapy, 19(11), 962-966. https://doi.org/10.1080/15384047.2018.1480282
Du, Xue, et al. "." Cancer biology & therapy vol. 19,11 (2018): 962-966. doi: https://doi.org/10.1080/15384047.2018.1480282
Du X, Shao Y, Gao H, Zhang X, Zhang H, Ban Y, Qin H, Tai Y. . Cancer Biol Ther. 2018;19(11):962-966. doi: 10.1080/15384047.2018.1480282. Epub 2018 Oct 01. PMID: 30273505; PMCID: PMC6301797.
Copy Download .nbib Format: NLM
Share it on

Cancer Biol Ther. 2018;19(11):962-966. doi: 10.1080/15384047.2018.1480282. Epub 2018 Oct 01.

[No title available]

Cancer biology & therapy

Xue Du, Yun Shao, Hongjun Gao, Xueli Zhang, Han Zhang, Yi Ban, Haifeng Qin, Yanhong Tai

Affiliations

  1. a Department of Pathology, Hospital of Chinese PLA , Cancer Center of People's Liberation Army of China , Beijing , China.
  2. b Department of Lung Cancer, Hospital of Chinese PLA , Cancer Center of People's Liberation Army of China , Beijing , China.

PMID: 30273505 PMCID: PMC6301797 DOI: 10.1080/15384047.2018.1480282

Abstract

The targeted treatment of advanced non-small cell lung cancer (NSCLC) harboring genomic rearrangement of

Keywords: ; ALK-tyrosine kinase inhibitor (TKI); Anaplastic lymphoma kinase (; crizotinib; fusion partner gene; rearranged NSCLC

References

  1. Lancet Oncol. 2015 Jul;16(7):e342-51 - PubMed
  2. Clin Cancer Res. 2012 Sep 1;18(17):4682-90 - PubMed
  3. Clin Lung Cancer. 2014 Sep;15(5):313-9 - PubMed
  4. J Thorac Oncol. 2014 Apr;9(4):563-6 - PubMed
  5. Oncologist. 2016 Jun;21(6):762-70 - PubMed
  6. Cancer Discov. 2012 Jun;2(6):495-502 - PubMed
  7. J Thorac Oncol. 2015 Jun;10(6):e37-9 - PubMed
  8. Cancer. 2011 Jun 15;117(12):2709-18 - PubMed
  9. Nat Rev Cancer. 2013 Nov;13(11):772-87 - PubMed
  10. CA Cancer J Clin. 2015 Mar;65(2):87-108 - PubMed
  11. Eur Respir J. 2017 Apr 12;49(4): - PubMed
  12. Sci Transl Med. 2012 Feb 8;4(120):120ra17 - PubMed
  13. CA Cancer J Clin. 2013 Jan;63(1):11-30 - PubMed
  14. J Clin Oncol. 2013 Mar 10;31(8):1105-11 - PubMed
  15. Curr Treat Options Oncol. 2017 Jun;18(6):36 - PubMed
  16. PLoS One. 2012;7(2):e31323 - PubMed
  17. J Clin Oncol. 2016 Mar 1;34(7):661-8 - PubMed
  18. Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907 - PubMed
  19. N Engl J Med. 2014 Dec 4;371(23):2167-77 - PubMed
  20. Clin Cancer Res. 2012 Mar 1;18(5):1472-82 - PubMed
  21. N Engl J Med. 2013 Jun 20;368(25):2385-94 - PubMed
  22. Nature. 2007 Aug 2;448(7153):561-6 - PubMed
  23. Nat Rev Clin Oncol. 2014 Aug;11(8):473-81 - PubMed
  24. Onco Targets Ther. 2016 Apr 05;9:1989-95 - PubMed
  25. Clin Cancer Res. 2009 May 1;15(9):3143-9 - PubMed
  26. J Thorac Oncol. 2014 Mar;9(3):285-94 - PubMed

Publication Types